Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTate & Lyle Regulatory News (TATE)

Share Price Information for Tate & Lyle (TATE)

Share Price is delayed by 15 minutes
Get Live Data
569.00    3.00 (0.53%)
Bid:
569.00
Ask:
570.00
Spread: 1.00 (0.176%)
Market Cap: £2.52b
TATE Live PriceLast checked at - London Stock Exchange

Intraday Tate & Lyle Share Chart

Director/PDMR Shareholding

23 Nov 2016 10:06

Tate & Lyle PLC

Notification of transactions by Person Discharging Managerial Responsibilities

Tate & Lyle PLC (the ‘Company’) announces that on 22 November 2016 Nick Hampton, a Person Discharging Managerial Responsibilities, exercised 96,680 nil-cost options over ordinary shares of 25 pence each in the capital of the Company (‘Shares’), in accordance with the Restricted Share Award that was granted to him on 18 November 2014, details of which are set out in the Annual Report 2015. 45,600 Shares were sold at 696.00 pence per Share on the London Stock Exchange to cover Mr Hampton’s tax liabilities and sale costs. Mr Hampton retained the remaining Shares and now holds an interest in a total of 122,161 Shares in the Company.

The notifications below, which have been made in accordance with the requirements of the EU Market Abuse Regulation, provide further detail.

Lucie Gilbert

Company Secretary

23 November 2016

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1. Details of PDMR / person closely associated with them (“PCA”)
a) Name Nick Hampton
2. Reason for the notification
a) Position / status PDMR – Chief Financial Officer
b) Initial notification / amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Tate & Lyle PLC
b) LEI 2138008K14474WPKZ244
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument

Identification code

Ordinary shares of 25 pence each in the capital of Tate & Lyle PLC

GB0008754136

b) Nature of the transaction Exercise of nil-cost options over shares for no consideration
c) Price(s) and volume(s)

Price(s) Volume(s)

Nil 96,680

d) Aggregated information

Aggregated volume Price

96,680

Nil

e) Date of the transaction 2016-11-22
f) Place of the transaction Outside a trading venue

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1. Details of PDMR / person closely associated with them (“PCA”)
a) Name Nick Hampton
2. Reason for the notification
a) Position / status PDMR – Chief Financial Officer
b) Initial notification / amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Tate & Lyle PLC
b) LEI 2138008K14474WPKZ244
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument

Identification code

Ordinary shares of 25 pence each in the capital of Tate & Lyle PLC

GB0008754136

b) Nature of the transaction Sale of shares to cover tax liabilities and sale costs arising on exercise of options.
c) Price(s) and volume(s)

Price(s) Volume(s)

GBP6.96 45,600

d) Aggregated information

Aggregated volume Price

45,600

GBP317,376

e) Date of the transaction 2016-11-22
f) Place of the transaction London Stock ExchangeXLON

View source version on businesswire.com: http://www.businesswire.com/news/home/20161123005212/en/

Copyright Business Wire 2016

Date   Source Headline
18th May 202611:02 amRNSForm 8.3 Tate & Lyle plc
18th May 202610:33 amRNSForm 8.5 (EPT/RI)
15th May 20263:20 pmRNSForm 8.3 - Tate & Lyle plc
15th May 20263:16 pmRNSForm 8.3 - Tate & Lyle plc
15th May 20263:12 pmRNSForm 8.3 - Tate & Lyle plc
15th May 20263:11 pmRNSForm 8.3 - Tate & Lyle plc
15th May 20262:53 pmRNSForm 8.3 Tate & Lyle Plc
15th May 20262:35 pmEQSForm 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc
15th May 20261:52 pmRNSForm 8.3 Tate & Lyle plc
15th May 20261:15 pmRNSForm 8.3 - Tate & Lyle Plc
15th May 20261:14 pmRNSForm 8.5 (EPT/NON-RI)- TATE & LYLE PLC
15th May 20261:11 pmRNSForm 8.5 (EPT/NON-RI)-TATE & LYLE PLC
15th May 20261:10 pmRNSForm 8.3 TATE & LYLE PLC
15th May 202612:51 pmRNSForm 8.3 - Tate & Lyle Plc
15th May 202612:28 pmPRNInvesco Ltd: Form 8.3 - Tate & Lyle PLC; Opening Position disclosure
15th May 202612:23 pmRNSForm 8.3 - Tate & Lyle plc
15th May 202611:53 amRNSForm 8.5 (EPT/RI)-Tate & Lyle plc
15th May 202611:35 amRNSForm 8.5 (EPT/RI)-Tate & Lyle plc
15th May 202611:29 amRNSForm 8.5 (EPT/NON-RI)-Tate & Lyle plc
15th May 202611:28 amBUSForm 8.3 - TATE & LYLE PLC
15th May 202611:25 amRNSForm 8.3 - Tate & Lyle PLC
15th May 202611:20 amRNSForm 8.5 (EPT/NON-RI)-Tate & Lyle plc
15th May 202611:09 amRNSForm 8.3 - Tate & Lyle plc
15th May 202611:06 amRNS20260514_TATE & LYLE_8.5 EPT NON-RI_UK_BOFASE
15th May 202611:04 amRNS20260514_TATE & LYLE_8.5 EPT RI_UK_MLI
15th May 202610:56 amRNSForm 8.3 Tate & Lyle PLC
15th May 202610:49 amPRNForm 8.3 - Tate & Lyle PLC
15th May 202610:24 amBUSDimensional Fund Advisors Ltd. : Form 8.3 - TATE & LYLE PLC - Ordinary Shares
15th May 20268:56 amRNSForm 8.5 (EPT/RI)
14th May 20264:15 pmRNSPossible 595 pence all-cash offer for Tate & Lyle
14th May 20263:25 pmRNSForm 8.3 - Tate & Lyle plc
14th May 20261:24 pmRNSDisclosure Table
14th May 20261:07 pmRNSStatement re Possible Offer for Tate & Lyle
1st May 202610:00 amRNSTotal Voting Rights
1st Apr 20264:00 pmRNSHolding(s) in Company
27th Mar 20262:00 pmRNSHolding(s) in Company
13th Mar 20264:00 pmRNSHolding(s) in Company
2nd Mar 20262:00 pmRNSHolding(s) in Company
26th Feb 20267:00 amRNSTrading Statement
23rd Feb 202610:00 amRNSHolding(s) in Company
17th Feb 202612:00 pmRNSHolding(s) in Company
21st Jan 20267:00 amRNSDirectorate change
15th Jan 20269:00 amRNSHolding(s) in Company
12th Jan 202610:00 amRNSHolding(s) in Company
7th Jan 20264:30 pmRNSDirector/PDMR Shareholding
7th Jan 20262:30 pmRNSBlock listing Interim Review
18th Dec 20252:00 pmRNSDirector/PDMR Shareholding
18th Dec 20252:00 pmRNSDirector/PDMR Shareholding
11th Dec 202512:18 pmRNSDirector/PDMR Shareholding
9th Dec 20259:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.